tissue microarray (Asterand Inc)
90
Structured Review
Asterand Inc
tissue microarray
Tissue Microarray, supplied by Asterand Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Custom+Tissue+Arrays/tissue+microarray/pmc04203382-59-1-22
Average 90 stars, based on 1 article reviews
Tissue Microarray, supplied by Asterand Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Custom+Tissue+Arrays/tissue+microarray/pmc04203382-59-1-22
Average 90 stars, based on 1 article reviews
tissue microarray - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Assessment of folate receptor-β expression in human neoplastic tissues Article Snippet: The cancer tissue microarrays that were examined in this study were: i) a hepatocellular carcinoma tissue microarray from Emory University (Atlanta, GA), ii) a thymoma tissue microarray from Indiana University-Purdue University Indianapolis (Indianapolis, IN), iii) a Article Title: Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy Article Snippet: A Article Title: The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease Article Snippet: A pilot custom TMA included 8 normal-tumor bladder tissue pairs and additionally, 1 unpaired bladder tumor, and 3 Article Title: Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies Article Snippet: The cancer tissue microarrays examined consisted of a pancreatic cancer microarray from the Translational Genomics Research Institute (Phoenix, AZ), a Article Title: Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer Article Snippet: A Article Title: Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy. Article Snippet: Purpose: The aim of the study was to investigate the vascular and stromal architecture of preclinical tumor models and patient tumor specimens from malignancies with known clinical outcomes to VEGFi treatment, to gain insight into potential determinants of intrinsic sensitivity and resistance.. Experimental Design: The tumor stroma architecture of preclinical and clinical tumor samples were analyzed by staining for CD31 and a-smooth muscle actin (a-SMA).. Tumor models representative of each phenotype were then tested for sensitivity to the VEGFR2-blocking antibody DC101. Microarray:Article Title: The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease Article Snippet: .. A Expressing:Article Title: Ferroportin antibodies and methods of use Article Snippet: A preliminary study using 31A5 and an Asterand human multi tissue array suggests that ferroportin is expressed in several different tissues (Table 3). .. TABLE 3 Ferroportin expression as assessed by IHC using 31A5 and an Immunohistochemistry:Article Title: Ferroportin antibodies and methods of use Article Snippet: A preliminary study using 31A5 and an Asterand human multi tissue array suggests that ferroportin is expressed in several different tissues (Table 3). .. TABLE 3 Ferroportin expression as assessed by IHC using 31A5 and an |